Dr. SriniVas R. Sadda Recognized with Retina Research Foundation Merit Award for Groundbreaking Research on Retinal Disease
October 14, 2023 — SriniVas R. Sadda, MD, director of the Doheny Eye Institute “Doheny”) Artificial Intelligence Laboratory, Professor of Ophthalmology at UCLA David Geffen School of Medicine, and one of the foremost experts on the retina, received the prestigious Retina Research Foundation (RRF) Merit Award for his contributions in retina research. The award, which established in 1978 grants Dr. Sadda $45,000 to continue his innovative work.
“The Merit Award in Retina Research is a testament to Dr. Sadda’s exceptional work in the field” noted Deborah A. Ferrington, Chief Scientific Officer at Doheny. “The impact of Dr. Sadda’s work extends globally. His advancements in understanding retinal diseases using artificial intelligence to identify disease biomarkers are expected to lead to earlier detection that potentially saves sight for millions of people around the world. Doheny proudly celebrates Dr. Sadda’s achievements and continued success.”
This recognition holds special significance as it marks two decades since the late Dr. Stephen J. Ryan, former Doheny President, received the same accolade in 2003. Dr. Sadda’s achievement follows in the footsteps of a distinguished legacy, reinforcing Doheny Eye Institute’s commitment to excellence in retina research.
In addition to receiving the Merit Award, Dr. Sadda recently delivered the Charles L. Schepens MD Lecture at the Retina Society’s 56th Annual Scientific Meeting on Thursday, October 12, 2023. Dr. Sadda’s presentation, titled “Insights into Pathophysiology of AMD (Age-Related Macular Degeneration) Revealed by High-Resolution Imaging,” captivated the audience, shedding light on groundbreaking advancements in the understanding of AMD, the leading cause of blindness among people aged 50 and older in developed nations.
About Doheny Eye Institute
Doheny Eye Institute is one of the nation’s leading vision research institutions with a history dating back to over 75 years. Doheny scientists and clinical scientists remain at the forefront of vision science investigating diabetic retinopathy, uveitis, age-related macular degeneration, and the use of artificial intelligence in helping to diagnose ocular disease.
Since 2013, the Doheny and UCLA Stein Eye Institute affiliation combine the strength, reputation, and distinction of two of the nation’s top eye institutes to advance vision research, education, and patient care in Southern California. Together, Doheny Eye Institute and UCLA Stein Institute are ranked in the Top 5 vision centers in the country by U.S. News & World Report.